Small vessel disease and biomarkers of endothelial dysfunction after ischaemic stroke
- PMID: 31259260
- PMCID: PMC6591766
- DOI: 10.1177/2396987318805905
Small vessel disease and biomarkers of endothelial dysfunction after ischaemic stroke
Abstract
Introduction: Although pathogenesis of small vessel disease is poorly understood, increasing evidence suggests that endothelial dysfunction may have a relevant role in development and progression of small vessel disease. In this cross-sectional study, we investigated the associations between imaging signs of small vessel disease and blood biomarkers of endothelial dysfunction at two different time points in a population of ischaemic stroke patients.
Patients and methods: In stroke patients treated with intravenous thrombolysis, we analysed blood levels of von Willebrand factor, intercellular adhesion molecule-1, vascular cell adhesion molecule-1 and vascular endothelial growth factor. Three reviewers independently assessed small vessel disease features using computed tomography. At baseline and 90 days after the index stroke, we tested the associations between single and combined small vessel disease features and levels of blood biomarkers using linear regression analysis adjusting for age, sex, hypertension, diabetes, smoke.
Results: A total of 263 patients were available for the analysis. Mean age (±SD) was 69 (±13) years, 154 (59%) patients were male. We did not find any relation between small vessel disease and endothelial dysfunction at baseline. At 90 days, leukoaraiosis was independently associated with intercellular adhesion molecule-1 (β = 0.21; p = 0.016) and vascular cell adhesion molecule-1 (β = 0.22; p = 0.009), and lacunes were associated with vascular endothelial growth factor levels (β = 0.21; p = 0.009) whereas global small vessel disease burden was associated with vascular endothelial growth factor (β = 0.26; p = 0.006).
Discussion: Leukoaraiosis and lacunes were associated with endothelial dysfunction, which could play a key role in pathogenesis of small vessel disease.
Conclusions: Small vessel disease features and total burden were associated with endothelial dysfunction 90 days after the stroke, whereas there was no relation during the acute phase. Our results suggest that endothelial dysfunction, particularly vascular endothelial growth factor, is involved in pathological process of small vessel disease.
Keywords: Small vessel disease; acute stroke; endothelial dysfunction; intercellular adhesion molecule; vascular cell adhesion molecule; vascular endothelial growth factor.
Figures
Similar articles
-
Small Vessel Disease Is Associated with Tissue Inhibitor of Matrix Metalloproteinase-4 After Ischaemic Stroke.Transl Stroke Res. 2019 Feb;10(1):44-51. doi: 10.1007/s12975-018-0627-x. Epub 2018 Apr 23. Transl Stroke Res. 2019. PMID: 29687301
-
Leukoaraiosis and lacunes are associated with poor clinical outcomes in ischemic stroke patients treated with intravenous thrombolysis.Int J Stroke. 2016 Jan;11(1):62-7. doi: 10.1177/1747493015607517. Int J Stroke. 2016. PMID: 26763021
-
Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis.Brain. 2003 Feb;126(Pt 2):424-32. doi: 10.1093/brain/awg040. Brain. 2003. PMID: 12538408
-
A Scoping Review on Biomarkers of Endothelial Dysfunction in Small Vessel Disease: Molecular Insights from Human Studies.Int J Mol Sci. 2023 Aug 23;24(17):13114. doi: 10.3390/ijms241713114. Int J Mol Sci. 2023. PMID: 37685924 Free PMC article.
-
Inflammation and cerebral small vessel disease: A systematic review.Ageing Res Rev. 2019 Aug;53:100916. doi: 10.1016/j.arr.2019.100916. Epub 2019 Jun 10. Ageing Res Rev. 2019. PMID: 31181331
Cited by
-
Associations Between CSF Markers of Inflammation, White Matter Lesions, and Cognitive Decline in Individuals Without Dementia.Neurology. 2023 Apr 25;100(17):e1812-e1824. doi: 10.1212/WNL.0000000000207113. Epub 2023 Mar 7. Neurology. 2023. PMID: 36882326 Free PMC article.
-
Small vessel disease and collaterals in ischemic stroke patients treated with thrombectomy.J Neurol. 2022 Sep;269(9):4708-4716. doi: 10.1007/s00415-022-11099-7. Epub 2022 Apr 6. J Neurol. 2022. PMID: 35384484
-
Endothelial cells as key players in cerebral small vessel disease.Nat Rev Neurosci. 2025 Mar;26(3):179-188. doi: 10.1038/s41583-024-00892-0. Epub 2025 Jan 2. Nat Rev Neurosci. 2025. PMID: 39743557 Review.
-
Soluble Biomarkers of Cerebrovascular Pathologies.Stroke. 2024 Apr;55(4):801-811. doi: 10.1161/STROKEAHA.123.044172. Epub 2024 Mar 25. Stroke. 2024. PMID: 38527143 Free PMC article. Review.
-
Biomarkers involved in the pathogenesis of cerebral small-vessel disease.Front Neurol. 2022 Sep 1;13:969185. doi: 10.3389/fneur.2022.969185. eCollection 2022. Front Neurol. 2022. PMID: 36119691 Free PMC article. Review.
References
-
- Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010; 9: 689–701. - PubMed
-
- Norrving B. Lacunar infarcts: no black holes in the brain are benign. Pract Neurol 2008; 8: 222–228. - PubMed
-
- Stevenson SF, Doubal FN, Shuler K, et al. A systematic review of dynamic cerebral and peripheral endothelial function in lacunar stroke versus controls. Stroke 2010; 41: 434–442. - PubMed
-
- Hassan A, Hunt BJ, O’Sullivan M, et al. Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain 2003; 126: 424–432. - PubMed
LinkOut - more resources
Full Text Sources